Skip to main content
FEMY
NASDAQ Life Sciences

Q3 Revenue Falls 45% to $404K, Missing Estimates; Loss Per Share 53 Cents

Tom Rudovsky · Reported by Reuters
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.44
Mkt Cap
$11.893M
52W Low
$1.255
52W High
$20.8
52W Position info
15% above low
Off High info
93% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

FEMY is trading near its 52-week low of $1.255 (15% above the low) on light trading volume (0.1× avg).

Summary

Femasys posted Q3 revenue of $404,597, down 44.5% year over year, and missed the $619,500 analyst consensus by a wide margin. The adjusted loss came in at 53 cents per share versus the 52-cent consensus, with a net loss of $4.56 million. Management attributed the sales drop to international FemBloc order timing, so the shortfall looks like lumpy ordering rather than lost demand, but the top-line miss is still large relative to a company this size. This follows the 8-K filed minutes earlier with the same figures and comes after an August FDA approval for a modular PMA submission approach for FemBloc and a UNC Health partnership. The stock has lost 87.9% this year and 35.2% this quarter, and the $30M August private placement plus the pending $3.1 million lawsuit over its terms remain the key overhangs.

At the time of this announcement, FEMY was trading at $1.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.9M. The 52-week trading range was $1.26 to $20.80. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

FEMY - Latest Insights

FEMY
Sep 29, 2026, 7:02 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $2.38
Real-time Price: $1.44 info
Change: -$0.940 (-39%) info
Market Cap: $11.893M info
FEMY
Sep 03, 2026, 5:06 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $3.04
Real-time Price: $1.44 info
Change: -$1.60 (-53%) info
Market Cap: $11.893M info
FEMY
Aug 26, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.88
Real-time Price: $1.44 info
Change: -$1.44 (-50%) info
Market Cap: $11.893M info
FEMY
Aug 19, 2026, 9:02 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.15
Real-time Price: $1.44 info
Change: -$0.710 (-33%) info
Market Cap: $11.893M info
FEMY
Aug 14, 2026, 4:28 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.34
Real-time Price: $1.44 info
Change: -$0.900 (-38%) info
Market Cap: $11.893M info